⚠️ SERVICE NOTICE: This instance will be decommissioned 1 december of this year (2026).
Please migrate your projects to our new repository:
https://gitrepo.service.rug.nl
Sites now go from systemic, IV, meningitis, endocarditis, pneumonia and mastitis to UTI, topical and screen. A breakpoint without a site takes the position of "other", as both mean any site that is not listed next to it. A second site breaks a tie on the first one.
The veterinary sites are now fixed codes as well: mastitis (includes Mammary gland), respiratory, metritis, genital, soft tissue and wounds (includes Abscesses). Sites that are part of each other do not contradict.
site = "other" now leaves out every breakpoint limited to an indication, and prefers a breakpoint without a site.
A rebuild of clinical_breakpoints with this order gives the same data, so the same blocking rows stay.
Implements the decisions ticked in #328, and the behaviour specified in https://github.com/msberends/AMR/pull/339#issuecomment-6577438074: `include_screening` now defaults to NULL, using screening breakpoints for screening agents only. With TRUE, a regular agent also takes these breakpoints, and with FALSE a screening agent gives NA with a note.
- antimicrobials gains 13 screening agents, e.g. GEN-S, ERY-S and STR1-S
- GEH and STH rows move to GEN-S and STR1-S, and as.sir() keeps accepting both codes
- Topical cut-off values move to -S agents with site "Topical"
- WHONET-based rows move as ticked, including CLSI cefoxitin for staphylococci and pefloxacin for Salmonella, and EUCAST 2012-2018 cefoxitin MIC
- Clinical breakpoints that EUCAST also allows as a screening test get a copy under the -S agent